Efficacy of Rifaximin in Preventing Campylobacteriosis
Clinical trial NCT02280044 · COMPLETED
Trial details
- NCT number
- NCT02280044
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2016-08-09
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.